Amongst the first monoclonal antibody used in the treatment of rheumatoid arthritis was . At the onset of the treatment, it is administered intravenously at the intervals of zero, two and six weeks, followed by every eight weeks subsequently. During the first year of the course, patients are scheduled to receive six infusions in all.

Previous ArticleRemicade: Medical Uses and Drug Facts Next ArticleSide Effects of Ketek
Verdicts and Settlements
Newsletter
Contact Us

Subscribe Now!

[contact-form-7 404 "Not Found"]

Follow Us!

Unsafe Drugs has numerous resources on drug side effects,nutritional supplements, vitamins, and health products.

Site best viewed in Google Chrome, Firefox, Opera, Safari, IE browsers